PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
293.08%
Net income growth 1.25-1.5x CRK's 213.29%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
No Data
No Data available this quarter, please select a different quarter.
185.71%
Well above CRK's 200.22% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Working capital change of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
100.00%
AR growth is negative or stable vs. CRK's 203.92%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-100.00%
Both negative yoy, with CRK at -100.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-100.00%
Negative yoy CFO while CRK is 98.90%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
15.56%
Lower CapEx growth vs. CRK's 100.00%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
100.00%
Acquisition growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-125.00%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
37.65%
Lower net investing outflow yoy vs. CRK's 100.00%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-100.00%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.